Last base update: 2018-08-01
Abasaglar | sol. to shock | 100 IU / ml 100 IU / ml Eli Lilly ( Insulin glargine ) | ||
The retail price, the price without refund | PLN 357.72 | |
Name of the indication | Type of refund | Patient's payment |
Type I diabetes in adults, adolescents and children from 6 years of age | medicine for 30% of the price | PLN 107.32 |
Type 2 diabetes mellitus in patients treated with NPH insulin for at least 6 months and with HbA1c ≥8% and type 2 diabetes in patients treated with NPH insulin for at least 6 months and with documented recurrent episodes of severe or nocturnal hypoglycaemia and type 1 diabetes in children from the age of 2 up to 6 years and diabetes of known cause (as defined by the WHO) | medicine for 30% of the price | PLN 107.32 |
Abilify | Table. | 15 mg 15 mg Otsuka Pharmaceutical Europe ( aripiprazole ) | ||
The retail price, the price without refund | PLN 137.09 | |
Name of the indication | Type of refund | Patient's payment |
Schizophrenia | medicine issued for a flat fee | PLN 3.20 |
Bipolar disorder | medicine issued for a flat fee | PLN 3.20 |
ABSENOR | Table. about release 300 mg 300 mg Orion Corporation ( Valproate sodium ) | ||
The retail price, the price without refund | 41.83 PLN | |
Name of the indication | Type of refund | Patient's payment |
Mental illness or mental retardation | medicine issued free of charge | PLN 0.21 |
Epilepsy | medicine issued for a flat fee | PLN 3.41 |
ABSENOR | Table. about release 500 mg 500 mg Orion Corporation ( Valproate sodium ) | ||
The retail price, the price without refund | PLN 69.37 | |
Name of the indication | Type of refund | Patient's payment |
Mental illness or mental retardation | medicine issued free of charge | 0.00 PLN |
Epilepsy | medicine issued for a flat fee | PLN 3.56 |
Accofil | solution for shock. and inf. | 30 million U / 0.5 ml | 30 million U / 0.5 ml | Accord Healthcare ( Filgrastim ) | ||
The retail price, the price without refund | PLN 127.57 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 14.74 |
Febrile neutropenia (neutropenic infection) in cases other than those specified in the SPC | medicine issued for a flat fee | PLN 14.74 |
neutropenia acquired in cases other than those specified in the SmPC | medicine issued for a flat fee | PLN 14.74 |
aplastic anemia | medicine issued for a flat fee | PLN 14.74 |
congenital neutropenia in cases other than those specified in the SPC | medicine issued for a flat fee | PLN 14.74 |
Accofil | solution for shock. and inf. | 48 million units / 0.5 ml 48 million units / 0.5 ml Accord Healthcare ( Filgrastim ) | ||
The retail price, the price without refund | PLN 942,38 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 17.31 |
Febrile neutropenia (neutropenic infection) in cases other than those specified in the SPC | medicine issued for a flat fee | PLN 17.31 |
neutropenia acquired in cases other than those specified in the SmPC | medicine issued for a flat fee | PLN 17.31 |
aplastic anemia | medicine issued for a flat fee | PLN 17.31 |
congenital neutropenia in cases other than those specified in the SPC | medicine issued for a flat fee | PLN 17.31 |
Accofil | solution for shock. and inf. | 48 million units / 0.5 ml 48 million units / 0.5 ml Accord Healthcare ( Filgrastim ) | ||
The retail price, the price without refund | PLN 198.48 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 16.02 |
Febrile neutropenia (neutropenic infection) in cases other than those specified in the SPC | medicine issued for a flat fee | PLN 16.02 |
neutropenia acquired in cases other than those specified in the SmPC | medicine issued for a flat fee | PLN 16.02 |
aplastic anemia | medicine issued for a flat fee | PLN 16.02 |
congenital neutropenia in cases other than those specified in the SPC | medicine issued for a flat fee | PLN 16.02 |
Accofil | solution for shock. and inf. | 30 million U / 0.5 ml | 30 million U / 0.5 ml | Accord Healthcare ( Filgrastim ) | ||
The retail price, the price without refund | PLN 724.08 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 3.20 |
Accofil | solution for shock. and inf. | 30 million U / 0.5 ml | 30 million U / 0.5 ml | Accord Healthcare ( Filgrastim ) | ||
The retail price, the price without refund | PLN 593.67 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 16.68 |
Febrile neutropenia (neutropenic infection) in cases other than those specified in the SPC | medicine issued for a flat fee | PLN 16.68 |
neutropenia acquired in cases other than those specified in the SmPC | medicine issued for a flat fee | PLN 16.68 |
aplastic anemia | medicine issued for a flat fee | PLN 16.68 |
congenital neutropenia in cases other than those specified in the SPC | medicine issued for a flat fee | PLN 16.68 |
Accofil | solution for shock. and inf. | 48 million units / 0.5 ml 48 million units / 0.5 ml Accord Healthcare ( Filgrastim ) | ||
The retail price, the price without refund | PLN 1132,89 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 3.20 |
accordeon | Table. about release 20 mg 20 mg Accord Healthcare ( Oxycodone hydrochloride ) | ||
The retail price, the price without refund | PLN 142.09 | |
Name of the indication | Type of refund | Patient's payment |
Malignant neoplasms | medicine issued for a flat fee | PLN 3.20 |
Postherpetic neuralgia chronic | medicine issued for a flat fee | PLN 3.20 |
Multiple-type local pain syndrome type I - reflex sympathetic dystrophy and type II - causalgia | medicine issued for a flat fee | PLN 3.20 |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 3.20 |
accordeon | Table. about release 10 mg 10 mg Accord Healthcare ( Oxycodone hydrochloride ) | ||
The retail price, the price without refund | 81.39 PLN | |
Name of the indication | Type of refund | Patient's payment |
Malignant neoplasms | medicine issued for a flat fee | PLN 3.20 |
Postherpetic neuralgia chronic | medicine issued for a flat fee | PLN 3.20 |
Multiple-type local pain syndrome type I - reflex sympathetic dystrophy and type II - causalgia | medicine issued for a flat fee | PLN 3.20 |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 3.20 |
accordeon | Table. about release 80 mg 80 mg Accord Healthcare ( Oxycodone hydrochloride ) | ||
The retail price, the price without refund | PLN 530.87 | |
Name of the indication | Type of refund | Patient's payment |
Malignant neoplasms | medicine issued for a flat fee | PLN 11.38 |
Postherpetic neuralgia chronic | medicine issued for a flat fee | PLN 11.38 |
Multiple-type local pain syndrome type I - reflex sympathetic dystrophy and type II - causalgia | medicine issued for a flat fee | PLN 11.38 |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 11.38 |
accordeon | Table. about release 40 mg 40 mg Accord Healthcare ( Oxycodone hydrochloride ) | ||
The retail price, the price without refund | PLN 271.69 | |
Name of the indication | Type of refund | Patient's payment |
Malignant neoplasms | medicine issued for a flat fee | 5.69 PLN |
Postherpetic neuralgia chronic | medicine issued for a flat fee | 5.69 PLN |
Multiple-type local pain syndrome type I - reflex sympathetic dystrophy and type II - causalgia | medicine issued for a flat fee | 5.69 PLN |
In all registered indications as at the date of the decision | medicine issued for a flat fee | 5.69 PLN |
accordeon | Table. about release 5 mg 5 mg Accord Healthcare ( Oxycodone hydrochloride ) | ||
The retail price, the price without refund | PLN 43.37 | |
Name of the indication | Type of refund | Patient's payment |
Malignant neoplasms | medicine issued for a flat fee | PLN 3.20 |
Postherpetic neuralgia chronic | medicine issued for a flat fee | PLN 3.20 |
Multiple-type local pain syndrome type I - reflex sympathetic dystrophy and type II - causalgia | medicine issued for a flat fee | PLN 3.20 |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 3.20 |
Acenocumarol WZF | Table. | 4 mg 4 mg Polfa Warsaw ( Acenocoumarol ) | ||
The retail price, the price without refund | PLN 11.86 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 5.12 |
Acidum zoledronicum medac | solution for inf. | 4 mg / 100 ml 4 mg / 100 ml medac ( Zoledronic acid ) | ||
The retail price, the price without refund | PLN 120.43 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 3.20 |
Acidum zoledronicum medac | ending to sol. to inf. | 4 mg / 5 ml 4 mg / 5 ml medac ( Zoledronic acid ) | ||
The retail price, the price without refund | PLN 195.27 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 78.04 |
Acitren | hard caps 25 mg 25 mg Sun-Farm ( Acitretin ) | ||
The retail price, the price without refund | PLN 399.96 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 7.62 |
Acitren | hard caps 25 mg 25 mg Sun-Farm ( Acitretin ) | ||
The retail price, the price without refund | PLN 127.57 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 3.20 |
Acitren | hard caps 10 mg 10 mg Sun-Farm ( Acitretin ) | ||
The retail price, the price without refund | PLN 167.27 | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 3.20 |
Acitren | hard caps 10 mg 10 mg Sun-Farm ( Acitretin ) | ||
The retail price, the price without refund | 54.40 PLN | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine issued for a flat fee | PLN 6.57 |
Actelsar HCT | Table. | 80 mg + 12.5 mg 80 mg + 12.5 mg Actavis Group ( telmisartan ) | ||
The retail price, the price without refund | 31.65 PLN | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine for 30% of the price | PLN 13.15 |
Actelsar HCT | Table. | 80 mg + 12.5 mg 80 mg + 12.5 mg Actavis Group ( Hydrochlorothiazide ) | ||
The retail price, the price without refund | 31.65 PLN | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine for 30% of the price | PLN 13.15 |
Actelsar HCT | Table. | 80 mg + 25 mg 80 mg + 25 mg Actavis Group ( telmisartan ) | ||
The retail price, the price without refund | 31.65 PLN | |
Name of the indication | Type of refund | Patient's payment |
In all registered indications as at the date of the decision | medicine for 30% of the price | PLN 13.15 |